Skip to content
LGBTQ News

FDA approves generic version of twice-yearly PrEP injection that could substantially lower the price

FDA approves generic version of twice-yearly PrEP injection that could substantially lower the price
Photo: LGBTQ Nation · view original
FacebookXWhatsAppEmail

The FDA approved a generic version of lenacapavir, a medication used to prevent the transmission of HIV as a form of PrEP. The medication's price is now expected to drop sharply where it's available. Lenacapavir, marketed as Yeztugo, was approved in 2025 and can protect a person from HIV for up to s

Sources and story details